0.3186
Schlusskurs vom Vortag:
$0.3325
Offen:
$0.33
24-Stunden-Volumen:
346.15K
Relative Volume:
2.16
Marktkapitalisierung:
$16.70M
Einnahmen:
$30.31M
Nettoeinkommen (Verlust:
$-22.84M
KGV:
-0.708
EPS:
-0.45
Netto-Cashflow:
$-22.61M
1W Leistung:
-25.30%
1M Leistung:
-34.32%
6M Leistung:
-71.81%
1J Leistung:
-74.71%
Enzo Biochem Inc Stock (ENZ) Company Profile
Firmenname
Enzo Biochem Inc
Sektor
Branche
Telefon
(516) 755-5500
Adresse
60 EXECUTIVE BLVD, FARMINGDALE, NY
Vergleichen Sie ENZ mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ENZ
Enzo Biochem Inc
|
0.3186 | 16.70M | 30.31M | -22.84M | -22.61M | -0.45 |
![]()
TMO
Thermo Fisher Scientific Inc
|
470.03 | 177.32B | 42.88B | 6.34B | 7.27B | 16.53 |
![]()
DHR
Danaher Corp
|
197.90 | 141.59B | 23.88B | 3.90B | 5.30B | 5.28 |
![]()
IDXX
Idexx Laboratories Inc
|
410.76 | 33.29B | 3.90B | 887.87M | 798.08M | 10.67 |
![]()
A
Agilent Technologies Inc
|
109.67 | 31.28B | 6.53B | 1.26B | 1.31B | 4.35 |
![]()
IQV
Iqvia Holdings Inc
|
167.69 | 29.57B | 15.41B | 1.37B | 2.11B | 7.50 |
Enzo Biochem Inc Stock (ENZ) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2011-10-18 | Bestätigt | Rodman & Renshaw | Mkt Outperform |
2009-09-23 | Eingeleitet | Rodman & Renshaw | Mkt Outperform |
2007-09-13 | Eingeleitet | Lazard Capital | Buy |
Enzo Biochem Inc Aktie (ENZ) Neueste Nachrichten
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Virtu Financial LLC Takes $35,000 Position in Enzo Biochem, Inc. (NYSE:ENZ) - Defense World
Enzo Biochem stock hits 52-week low at $0.33 amid market challenges By Investing.com - Investing.com South Africa
Enzo Biochem to Delist from NYSE, Move to OTCQX - TipRanks
Enzo Biochem stock hits 52-week low at $0.33 amid market challenges - Investing.com Australia
StockNews.com Begins Coverage on Enzo Biochem (NYSE:ENZ) - Defense World
Enzo Biochem to delist from NYSE, move to OTCQX market By Investing.com - Investing.com South Africa
Enzo Biochem to voluntarily delist from NYSE and transfer trading of shares to OTCQX; shares fall - MSN
Enzo Biochem to delist from NYSE, move to OTCQX market - Investing.com India
Enzo Biochem (ENZ) to Voluntarily Delist from NYSE, Move to OTCQ - GuruFocus
Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQX - The Manila Times
Enzo Biochem Announces Notification to New York Stock - GlobeNewswire
Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily - Bluefield Daily Telegraph
NYSE Delisting Alert: Enzo Biochem Moving to OTCQXWhat Shareholders Must Know - Stock Titan
Here’s Why Enzo Biochem (ENZ) Declined in Q4 - Yahoo Finance
ENZ Stock Down Following Q2 Earnings, Revenues Decline Y/Y - Nasdaq
Enzo Biochem Inc (ENZ) Reports Q2 Fiscal 2025 Revenue of $7.3 Mi - GuruFocus.com
Enzo Biochem: Fiscal Q2 Earnings Snapshot - The Pioneer
Enzo Biochem Reports Decline in Quarterly Revenues - TipRanks
Enzo Biochem Inc. ($0.01 Par Value) (ENZ) reports earnings - Quartz
Enzo Biochem Stages Comeback: Q2 Shows 18% Growth, Key Segment Returns to Profit - StockTitan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Enzo Biochem: Fiscal Q2 Earnings Snapshot -March 17, 2025 at 04:30 pm EDT - Marketscreener.com
ENZO BIOCHEM INC SEC 10-Q Report - TradingView
Enzo Biochem Reports Second Quarter Fiscal Year 2025 Results - GlobeNewswire
Protein Stability Analysis Market Future Business - openPR
Enzo Biochem (NYSE:ENZ) Coverage Initiated by Analysts at StockNews.com - Defense World
Enzo Biochem, Inc. to Host Earnings Call - ACCESS Newswire
Enzo Biochem (NYSE:ENZ) Earns Hold Rating from Analysts at StockNews.com - Defense World
Protein Stability Analysis Market Generated Opportunities, - openPR
Enzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.com - Defense World
Enzo Biochem, Inc.'s (NYSE:ENZ) 28% Share Price Plunge Could Signal Some Risk - Simply Wall St
Enzo Biochem stock hits 52-week low at $0.51 amid challenges - MSN
ENZ Stock Earnings: Enzo Biochem Reported Results for Q3 2024 - MSN
Neuroscience Antibodies and Assays Market to Grow by USD 2.20 Billion from 2024-2028, Rising Neurological Disorders Boost Growth, Report on How AI is Redefining Market LandscapeTechnavio - The Malaysian Reserve
NYAG’s Enforcement of Mandated Cybersecurity Safeguards Sends Expensive Shock Waves through Varying Industries - Law.com
StockNews.com Initiates Coverage on Enzo Biochem (NYSE:ENZ) - Defense World
Enzo Biochem stock hits 52-week low at $0.63 amid market challenges - Investing.com Canada
Finanzdaten der Enzo Biochem Inc-Aktie (ENZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):